Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

SMMTSMMT
Showing 8 of 20 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in SUMMIT THERAPEUTICS INC

Bank of New York Mellon Corp holds 431,299 shares of SMMT (SUMMIT THERAPEUTICS INC), worth $6.3M as of 2026-Q2. The position was increased (+6.6% shares). SMMT represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$6.3M

Current Shares

431,299

Total Value Change

+$822,306

Total Shares Change

+181,906

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
431,299
+6.6%
$6.3M0.0%$14.57
29
2026-Q1
Increased
404,679
+14.4%
$7.7M0.0%$15.11
31
2025-Q4
Decreased
353,756
-3.6%
$6.2M0.0%$17.49
0
2025-Q3
Increased
367,126
+6.9%
$7.6M0.0%$21.16
29
2025-Q2
Increased
343,524
+0.8%
$7.3M0.0%$20.60
27
2025-Q1
Increased
340,775
+2.2%
$6.6M0.0%$20.32
28
2024-Q4
Increased
333,510
+33.7%
$6M0.0%$17.89
35
2024-Q3
Decreased
249,393
-11.1%
$5.5M0.0%$20.89
0

Other major holders of SMMT: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used